Ethos Technologies Inc.
Lingke Wang (President) sells LIFE shares
About this filing
Ethos Technologies Inc. (LIFE) filed Form 4 (insider transaction) with the SEC on Nov 20, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Lingke Wang · President, Director
Rule 10b5-1 plan · adopted May 20, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | C · conversionFootnotes F1, F2 | +83,197 | — | — | 1,598,133 | Direct |
| Nov 19, 2026 | S · open-market saleFootnotes F3, F4, F2 | −99,995 | $32.11 | $3,210,839.45 | 1,498,138 | Direct |
| Nov 19, 2026 | S · open-market saleFootnotes F3, F5, F2 | −18,338 | $32.62 | $598,185.56 | 1,479,800 | Direct |
| Nov 19, 2026 | C · conversionClass B Common StockFootnotes F1 | −83,197 | $0.00 | $0.00 | 3,609,753 | Direct |
Footnotes
- F1 Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. The Class B Common Stock has no expiration.
- F2 Includes shares issuable on settlement of restricted stock units.
- F3 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026, and occurred pursuant to the pre-established terms of such plan rather than as a result of a discretionary decision by the Reporting Person to sell shares at that time.
- F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.425 to $32.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.43 to $32.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 Shares held by The B 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F7 Shares held by The J 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F8 Shares held by The K 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F9 Shares held by The L 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F10 Shares held by The D 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F11 Shares held by The W 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
- F12 Shares held by The X 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
More LIFE filings
- 4
Filed Nov 20, 2026
- 144
Filed Nov 20, 2026
- 144
Filed Nov 19, 2026
- 144
Filed Nov 19, 2026
- 144
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.